Insilico Medicine and Tenacia Biotechnology Enhance AI-Powered CNS Collaboration in Landmark $94.75 Million Deal
Insilico Medicine, a pioneering clinical-stage biotechnology company specializing in generative artificial intelligence (AI) for drug discovery, has announced a significant ...
